The molecular mechanism that underlies lineage 'choice' in the thymus is a fundamental but still open question in immunology. A competent T cell immune system requires CD4 + helper T cells that recognize major histocompatibility complex (MHC) class II ligands and CD8 + effector T cells that recognize MHC class I ligands 1 . These characteristics are established during thymic selection by the transcription factor ThPOK (encoded by Zbtb7b; called 'Thpok' here), which induces thymocytes that have received MHC class II signaling to become CD4 + T cells 2,3 , and by the transcription factor Runx3, which induces cells that have received MHC class I signaling to become CD8 + T cells 4, 5 . Unambiguous lineage fate 'decisions' require that individual thymocytes express either ThPOK or Runx3 but not both. How such mutually exclusive expression of lineage-determining factors is achieved remains unresolved.
The molecular mechanism that underlies lineage 'choice' in the thymus is a fundamental but still open question in immunology. A competent T cell immune system requires CD4 + helper T cells that recognize major histocompatibility complex (MHC) class II ligands and CD8 + effector T cells that recognize MHC class I ligands 1 . These characteristics are established during thymic selection by the transcription factor ThPOK (encoded by Zbtb7b; called 'Thpok' here), which induces thymocytes that have received MHC class II signaling to become CD4 + T cells 2, 3 , and by the transcription factor Runx3, which induces cells that have received MHC class I signaling to become CD8 + T cells 4, 5 . Unambiguous lineage fate 'decisions' require that individual thymocytes express either ThPOK or Runx3 but not both. How such mutually exclusive expression of lineage-determining factors is achieved remains unresolved.
For Runx3-induced suppression of ThPOK, intrathymic cytokines signal thymocytes to express Runx3 proteins 6 that then bind to a silencer element in the Thpok locus to repress its transcription 7, 8 . As a result, thymocytes that have received cytokine signaling adopt the CD8 + lineage fate by upregulating Runx3 expression and repressing ThPOK expression [6] [7] [8] . In contrast, ThPOK does not bind to the Runx3 locus to repress its transcription. Consequently, it is not known how ThPOK antagonizes Runx3 and prevents adoption of the CD8 + lineage fate, nor is it known how ThPOK promotes adoption of the CD4 + lineage fate 9, 10 .
We undertook the present study to identify the mechanism by which ThPOK influences lineage fate determination in developing thymocytes. We found that ThPOK antagonized Runx3 expression by targeting and upregulating genes that encode cytosolic proteins of the SOCS (suppressor of cytokine signaling) family that negatively regulate cytokine signal transduction in T cells 11 . Notably, we observed that in T cells lacking expression of SOCS-encoding genes, ThPOK was functionally inert, as it neither prevented Runx3 expression nor prevented adoption of the CD8 + lineage fate. Reciprocally, in ThPOK-deficient mice, transgenic expression of SOCS1 was sufficient to prevent Runx3 expression and to promote the generation of CD4 + T cells despite the absence of functional ThPOK. We also determined that ThPOK upregulated expression of the coreceptor CD4 during MHC class II-specific positive selection and that that ThPOK function was independent of SOCS proteins. Thus, our study identifies the molecular mechanisms by which ThPOK induces developing T cells to adopt the CD4 + lineage fate during differentiation in the thymus.
RESULTS

ThPOK suppresses Runx3 expression in thymocytes
We began our study by assessing the development of CD4 + T cells in wild-type mice and in helper T cell-deficient (HD) mice (Thpok hd/hd mice) 12, 13 . In HD mice, Thpok encodes a nonfunctional 'ThPOK HD ' protein because of a naturally occurring point mutation in the genomic sequence encoding the second zinc-finger domain of ThPOK 2 . Consequently, the development of CD4 + helper T cells is abolished in HD mice, with the result that thymocytes that have received MHC class II signaling differentiate into CD8 + T cells instead of CD4 + T cells [12] [13] [14] . Such a requirement for ThPOK function was illustrated in HD mice expressing a transgene encoding the AND MHC class II-specific T cell antigen receptor (TCR) (Fig. 1a) . Unlike AND mice, AND Thpok hd/hd mice failed to generate CD4 + T cells, so that cells positive for the α-chain variable region 11 (V α 11) clonotypic TCR were redirected to the CD8 + lineage (Fig. 1a) . To understand the molecular basis of the requirement for functional ThPOK in differentiation into the CD4 + lineage, we examined thymocytes at the CD69 + CD4 + CD8 lo intermediate (INT) stage (Fig. 1b, left) , because it is in INT thymocytes that lineage fate is determined 1, 15, 16 . We found that ThPOK mRNA was expressed in INT thymocytes from both AND mice and AND Thpok hd/hd mice (Fig. 1b, right) . However, the ThPOK mRNA in AND thymocytes encoded functional ThPOK protein that prevented expression of Runx3 mRNA, whereas the ThPOK mRNA in AND Thpok hd/hd thymocytes encoded the nonfunctional ThPOK HD protein that permitted expression of Runx3 mRNA (Fig. 1b,  right) . As a result, AND Thpok hd/hd thymocytes adopted the CD8 + lineage fate and differentiated into CD4 − CD8 + single-positive (CD8SP) thymocytes and CD8 + T cells (Fig. 1a,b) . Thus, thymocytes did not simultaneously express functional ThPOK and Runx3.
ThPOK induces expression of SOCS-encoding genes A transgene encoding SOCS1 that impairs cytokine signaling has been shown to prevent thymocytes that have received MHC class I signaling from expressing Runx3 and differentiating into T cells of the CD8 + lineage 6, 17 . The SOCS family of cytosolic proteins suppress cytokine signaling either by interfering with cytokine receptorassociated kinases or by competing with STAT signal transducers for recruitment to activated cytokine receptors 11, 18 . At present, there are eight SOCS-encoding genes, of which at least three (Socs1, Socs3 and Cish) are expressed in T cells and encode proteins that impair cytokine signaling. Expression of SOCS-encoding genes is upregulated in cells that have received cytokine signaling to function as a negative feedback mechanism 11, 19 , but regulation of their expression is incompletely understood. Consequently, we sought to determine if ThPOK might induce expression of one or more of these SOCSencoding genes in developing thymocytes as the mechanism by which ThPOK antagonized Runx3.
We first compared the expression of SOCS-encoding genes in CD4 + CD8 − single-positive (CD4SP) and CD8SP wild-type thymocytes. During thymic selection in wild-type mice, INT thymocytes that have received cytokine signaling express Runx3 and differentiate into CD8SP cells, while INT thymocytes that have received MHC class II signaling express ThPOK and differentiate into CD4SP cells without receiving cytokine signals 1, 6, 7 . Consequently, signaling by intrathymic cytokines would account for the expression of SOCSencoding genes in CD8SP thymocytes, but it would not account for such expression in CD4SP thymocytes. Nevertheless, we found that wild-type CD4SP thymocytes did express mRNA from four different SOCS-encoding genes (Socs1, Socs3, Cish and Socs4), with expression of SOCS1 and Cish mRNA being even higher than that in wild-type CD8SP thymocytes (Fig. 1c) . Since these results were not explained by cytokine signaling, they suggested that CD4 + T cells contained an inducer of SOCS-encoding genes, which might be ThPOK.
To assess possible induction of the expression of SOCS-encoding genes by ThPOK, we constructed two new mouse lines, L1 and L6, with transgenic expression of ThPOK (ThPOK-Tg); their expression of ThPOK was different from that of the preexisting C8 ThPOK-Tg mouse line 3 . Together with wild-type (C57BL/6 (B6)) mice, the three ThPOK-Tg mouse lines formed an ascending hierarchy of ThPOK expression in CD4 + T cells in vivo (wild-type < L1 < C8 < L6) (Fig. 1d,  left) . All three ThPOK-encoding transgenes were driven by regulatory elements of the human gene encoding CD2 that forced ThPOK expression in all T lineage cells and caused nearly all thymocytes to A r t i c l e s adopt the CD4 + lineage fate (Fig. 1d, right) . In addition to having higher expression of ThPOK than that of wild-type CD4 + T cells, ThPOK-Tg CD4 + T cells had higher expression of SOCS1, SOCS3 and Cish mRNA ( Fig. 1e and Supplementary Fig. 1a ). In fact, the expression of each of those mRNAs was directly and quantitatively related to the expression of ThPOK mRNA in CD4 + T cells (Fig. 1e) . Such a direct quantitative relationship with ThPOK expression revealed that ThPOK was responsible, either directly or indirectly, for upregulating expression of those SOCS-encoding genes. The inductive effect of ThPOK on expression of SOCS-encoding genes was cell intrinsic (Supplementary Fig. 1b ) and was specific mainly for Socs1, Socs3 and Cish, with little effect on Socs4 (Fig. 1e) . These results identified Socs1, Socs3 and Cish as direct or indirect downstream targets of ThPOK.
ThPOK is a transcriptional activator of SOCS-encoding genes To demonstrate that the higher expression of SOCS-encoding genes was a direct effect of ThPOK expression and was not dependent on signaling via the TCR, we generated MHC class II-deficient mice with transgenic expression of ThPOK. In these mice, MHC class I-selected T cells are redirected into the CD4 + lineage and express mismatched CD4 coreceptors so that TCR signaling is absent. Notably, in these mice, the expression of SOCS-encoding genes increased with increasing expression of ThPOK (Fig. 2a) , which suggested that the inductive effect of ThPOK was not dependent on TCR signaling.
Next, to determine if ThPOK affected the transcription of SOCSencoding genes, we introduced a Socs1 reporter gene (in which sequence encoding a nonfunctional human CD4 protein was inserted into the endogenous Socs1 locus to report Socs1 transcriptional activity 20 ) into wild-type and ThPOK-Tg mice. We observed that sur face expression of the human CD4 reporter protein was directly and quantitatively related to the ThPOK mRNA content in CD4 + T cells (Fig. 2b) , which suggested that the inductive effect of ThPOK on expression of SOCS-encoding genes was transcriptional. Analysis of the 5′ upstream regulatory region of two such genes (Socs1 and Cish) revealed conserved noncoding sequences with two potential ThPOKbinding sites in each that corresponded to their promoter regions ( Supplementary Fig. 2 ). We cloned those promoter elements into a promoterless luciferase reporter vector to assess the effect of ThPOK on the promoters' activity. We found that the transcriptional activity of both the Socs1 promoter and the Cish promoter was increased in a dose-dependent manner by cotransfection of 293T human embryonic kidney cells with cDNA encoding functional ThPOK protein but was unaffected by cotransfection of cDNA encoding nonfunctional mutant ThPOK protein (Fig. 2c) . We concluded that ThPOK was able to specifically target the promoters of Socs1 and Cish to increase transcription.
ThPOK needs SOCS-encoding genes to suppress Runx3
We then assessed the possibility that induction of SOCS-encoding genes was the mechanism by which ThPOK suppressed Runx3 expression. We considered that ThPOK upregulated expression of at least three different SOCS-encoding genes (Socs1, Socs3 and Cish; Fig. 1e ), each of which could suppress cytokine signaling and prevent Runx3 expression 11, 18 . Because Socs1 had the highest expression among these genes in thymocytes, we examined the specific effect of germline deletion of Socs1 (Socs1 −/− ) on ThPOK-induced suppression of Runx3 expression. We ensured that all Socs1 −/− mice were also deficient in interferon-γ (IFN-γ; Socs1 −/− Ifng −/− mice) to avoid any possibility of IFN-γ-mediated inflammation, which might secondarily affect lineage fate 'decisions' in the thymus 21 .
Germline deletion of Socs1 did in fact influence lineage fate 'decisions' , as Socs1 −/− mice had a much higher frequency of CD8SP thymocytes and a lower ratio of CD4 + cells to CD8 + cells 21, 22 (Fig. 3a) . To directly assess the effect of SOCS1 deficiency on ThPOK function, we generated ThPOK-Tg Socs1 −/− mice in which all Socs1 −/− thymocytes expressed ThPOK. Whereas SOCS1-sufficient thymocytes from ThPOK-Tg mice and ThPOK-Tg Ifng −/− mice were devoid of CD8SP cells, SOCS1-deficient thymocytes from ThPOK-Tg Socs1 −/− Ifng −/− mice contained substantial numbers of mature (TCRβ hi ) CD8SP cells (Fig. 3b,c and Supplementary Fig. 3 ). The generation of those mature CD8SP cells was not due to variegated ThPOK-Tg expression, because CD8SP thymocytes from ThPOK-Tg Socs1 −/− mice had the same expression of ThPOK mRNA as that of their CD4SP counterparts (Fig. 3d) . Unexpectedly, those CD8SP thymocytes not only expressed ThPOK mRNA but also expressed Runx3 mRNA (Fig. 3d) . The Runx3 expressed was functional despite ThPOK expression, as revealed by expression of the Runx3 target gene Cd103 (ref. 23) (Fig. 3d) and by the appearance of mature CD8 + T cells in the periphery (Fig. 3e) . Thus, in the absence of SOCS1, transgenically expressed ThPOK failed to suppress Runx3 expression and failed to prevent developing thymocytes from adopting the CD8 + lineage fate, which resulted in unusual ThPOK-expressing CD8 + T cells.
To demonstrate that the effect of SOCS1 deficiency on the generation of CD8SP thymocytes in ThPOK-Tg mice was cell intrinsic A r t i c l e s and was not secondary to peripheral inflammation induced by SOCS1-deficient T cells, we performed two different types of experiments. First, we assessed the generation of mature CD8SP thymocytes in 9-day-old (neonatal) ThPOK-Tg Socs1 −/− mice that were IFN-γ deficient and were too young to have sufficient numbers of peripheral T cells to induce peripheral inflammation (Fig. 3f) . Nevertheless, we observed that mature (TCRβ hi ) CD8SP thymocytes were still generated in ThPOK-Tg Socs1 −/− Ifng −/− neonates (Fig. 3f) . Second, we assessed the generation of mature CD8SP thymocytes in immunodeficient (Rag2 −/− ) chimeras 8-10 weeks after reconstitution with a mixture of equal numbers of bone marrow stem cells from ThPOK-Tg Socs1 +/+ donor mice and ThPOK-Tg Socs1 −/− donor mice. In such chimeras, SOCS1-sufficient ThPOK-Tg thymocytes (identified by a Socs1 + allele) and SOCS1-deficient ThPOK-Tg thymocytes (identified by the absence of a Socs1 + allele and the presence of Socs1 −/− alleles) would both be equally subjected to peripheral inflammation induced by SOCS1-deficient T cells. Nevertheless, chimeric CD8SP thymocytes were entirely and exclusively of Socs1 −/− origin, unlike chimeric CD4SP thymocytes, which were of dual origin (Fig. 3g) . Thus, the inability of the transgenically expressed ThPOK to prevent SOCS1-deficient thymocytes from adopting the CD8 + lineage fate was cell intrinsic and was not secondary to peripheral inflammation. While ThPOK-Tg Socs1 −/− thymocyte populations included mature CD8 + T cells, it was evident that most thymocytes in ThPOKTg Socs1 −/− mice did not express Runx3 and did not adopt the CD8 + lineage fate (Fig. 3b-e) . To understand why this was true, we considered that ThPOK upregulated the expression of Socs3 and Cish, in 
npg
A r t i c l e s addition to upregulating the expression of Socs1. Consequently, we hypothesized that ThPOK-Tg Socs1 −/− cells that adopted the CD8 + lineage fate might not have upregulated expression of Socs3 or Cish in amounts sufficient to prevent Runx3 expression. This was precisely the case, as ThPOK-Tg Socs1 −/− CD8 + T cells had only low expression of SOCS3 and Cish mRNA, whereas ThPOK-Tg Socs1 −/− CD4 + T cells had high expression of both (Fig. 4a) . Notably, such CD8 + T cells were truly of the CD8 + T cell lineage because after being stimulated by antibody to the TCR and antibody to the costimulatory receptor CD28, they differentiated into cytotoxic effector cells with high expression of Runx3 and granzyme B (Fig. 4b,c) Fig. 4 ).
Transgenic expression of SOCS1 can replace ThPOK
Having discovered that ThPOK repressed Runx3 expression and the CD8 + lineage fate by inducing the expression of genes encoding members of the SOCS family, we sought to determine if expression of a transgene encoding a SOCS protein could overcome the requirement for ThPOK in CD4 + lineage 'choice' . To investigate this possibility, we introduced into HD mice a transgene encoding SOCS1 driven by proximal promoter-enhancer elements of Lck 24 (Thpok hd/hd SOCS1-Tg mice) and assessed expression of ThPOK and Runx3 mRNA. The transgene encoding SOCS1 did not alter expression of ThPOK mRNA in INT thymocytes from Thpok hd/hd SOCS1-Tg mice but it resulted in much lower expression of Runx3 mRNA (Fig. 5a) . Thus, INT thymocytes in Thpok hd/hd SOCS1-Tg mice lacked both of the lineagespecifying transcription factors ThPOK and Runx3. Nonetheless, these cells gave rise to mature (CD24 lo TCRβ hi ) CD4 + T cells in both the thymus and periphery (Fig. 5b) , with 14 × 10 6 CD4 + T cells in Thpok hd/hd SOCS1-Tg lymph nodes (Fig. 5c) . To exclude the possibility that these findings resulted from unappreciated functioning of ThPOK HD protein, we also introduced the transgene encoding SOCS1 into Thpok −/− mice that were completely devoid of ThPOK protein 25 . Analysis of Thpok −/− SOCS1-Tg mice again revealed the presence of npg mature CD4 + T cells in both the thymus and periphery (Fig. 6a) , with 15 × 10 6 CD4 + T cells in the lymph nodes (Fig. 6b) . Thus, expression of the transgene encoding SOCS1 in ThPOK-deficient mice resulted in the generation of ThPOK-deficient CD4 + T cells.
ThPOK upregulates CD4 expression during positive selection
To further understand the contribution of ThPOK to differentiation into the CD4 + lineage, we further characterized the ThPOKindependent CD4 + T cells that arose in Thpok hd/hd SOCS1-Tg mice. These cells were specific for MHC class II, as deficiency in MHC class II eliminated their generation (Fig. 5b) . As further evidence of their MHC class II specificity, ThPOK-independent CD4 + T cells were selected by the AND TCR, as shown by the presence of clonotypic V α 11 hi CD4 + T cells in both the thymus and periphery of AND Thpok hd/hd SOCS1-Tg mice (Fig. 7a) . The ThPOK-independent CD4 + T cells from AND Thpok hd/hd SOCS1-Tg mice were functional cells of the CD4 + lineage, as they produced interleukin 4 but not IFN-γ under T helper type 2-polarizing conditions ( Fig. 7b) and had helper function, as revealed by upregulation of the expression of the ligand for the costimulatory receptor CD40 in response to stimulation with antibody to the TCR (Fig. 7c) . Notably, we observed that ThPOK-independent CD4 + T cells differed from conventional CD4 + T cells in surface expression of CD4 (Figs. 5b, 6a and 7a) . Quantification of CD4 expression revealed that both the expression of CD4 mRNA and surface expression of CD4 protein were significantly lower in ThPOK-independent CD4 + T cells than in conventional wild-type CD4 + T cells (Fig. 7d) . The basis for this reduction was revealed by quantification of the surface expression of CD4 during positive selection in the thymus (Fig. 7e) . While CD4 expression was upregulated during the differentiation of INT thymocytes into mature CD4 + T cells in ThPOK-intact mice (i.e., wild-type mice and SOCS1-Tg mice), CD4 expression was not upregulated during differentiation in ThPOK-deficient mice (i.e., Thpok hd/hd SOCS1-Tg mice and Thpok −/− SOCS1-Tg mice) (Fig. 7e) . As a result, CD4 expression was significantly lower on ThPOK-deficient CD4SP thymocytes than on ThPOK-sufficient CD4SP thymocytes (Fig. 7e) . Thus, these results identified ThPOK as being responsible for the upregulation of CD4 expression during MHC class II-specific positive selection in the thymus.
Because upregulation of CD4 expression prevents TCR signaling from being prematurely disrupted during MHC class II-specific positive selection and increasing the potential for lineage errors 26 , the failure of ThPOK-deficient thymocytes to upregulate CD4 expression would result in increased lineage-specification errors. Consistent with this expectation, many MHC class II-selected thymocytes in AND Thpok hd/hd SOCS1-Tg mice did not differentiate into CD4 + T cells (Fig. 7a) . Thus, upregulation of CD4 expression during MHC class II-specific positive selection was a function of ThPOK that was not mediated by SOCS proteins.
DISCUSSION
ThPOK is considered the master regulator of CD4 + lineage fate because it directs positively selected thymocytes to differentiate into T cells of the CD4 + lineage regardless of the MHC specificity of their TCR 2,3,14 . However, the mechanism by which ThPOK imposes CD4 + lineage fate on developing T cells has remained enigmatic. Our study has now identified SOCS-encoding genes as direct targets of ThPOK and has documented that the induction of these genes by ThPOK prevented Runx3 expression and was responsible for CD4 + lineage-fate determination. Thus, ThPOK imposed the CD4 + helper T cell lineage fate on developing T cells by inducing the expression of SOCS-encoding genes to prevent Runx3 expression and block CD8 + lineage 'choice' .
We found that ThPOK targeted at least three genes (Socs1, Socs3 and Cish) encoding SOCS proteins that suppressed cytokine signaling in T cells and prevented the expression of Runx3. In cells lacking expression of SOCS-encoding genes, transgenically expressed ThPOK was observed to be functionally inert in that it permitted npg developing T cells to express Runx3 and to adopt the CD8 + cytotoxic T cell lineage fate. The resulting SOCS-deficient CD8 + cytotoxic T cells were unique among T cells in their simultaneous expression of both ThPOK and Runx3. Despite simultaneously expressing both of these lineage-specifying factors, the SOCS-deficient T cells that were Runx3 + displayed no ambiguity in their lineage fate 'decision' , as they differentiated into the CD8 + cytotoxic T cell lineage. Indeed, Runx3 seemed to be fully functional in SOCS-deficient CD8 + T cells despite the presence of ThPOK, as these cells expressed the cytotoxic-lineage molecules granzyme B and perforin. These unique T cells demonstrate that ThPOK must induce the expression of SOCS-encoding genes to prevent Runx3 expression and to impose the CD4 + lineage fate. T cells expressing dual lineage factors arose in ThPOK-Tg mice that were also deficient in SOCS1. Because ThPOK induced the expression of Socs3 and Cish in addition to that of Socs1, it was unexpected that deficiency in only Socs1 affected ThPOK function. However, SOCS1-deficient T cells in ThPOK-Tg mice that adopted the CD8 + lineage fate additionally lacked expression of both Socs3 and Cish, whereas T cells in the same mice that adopted the CD4 + lineage fate had high expression of Socs3 or Cish or both. We suggest that ThPOK is expressed in amounts that are insufficient to ensure binding to all or multiple ThPOK targets in every T cell so that ThPOK may bind randomly to different SOCS-expressing targets in individual T cells. If ThPOK binds only to Socs1 in some T cells, then ThPOK in those T cells in SOCS1-deficient mice will not induce expression of any SOCS protein, rendering transgenic ThPOK functionally inert and allowing those T cells to express Runx3 and to differentiate into the CD8 + cytotoxic T cell lineage, as we observed.
In addition to demonstrating that the expression of SOCS-encoding genes was required for ThPOK to promote CD4 + lineage specification, our study has also demonstrated the reciprocal result, in that enforced SOCS1 expression largely replaced ThPOK in the generation of CD4 + T cells. Specifically, transgenic expression of SOCS1 in ThPOKdeficient mice directed many MHC class II-selected cells to adopt the CD4 + lineage fate, which confirmed that the expression of SOCSencoding genes was the mechanism by which ThPOK promoted the CD4 + lineage fate. The observation that enforced SOCS1 expression obviated the need for ThPOK extends the understanding of CD4 + lineage specification and integrates together three disparate findings about lineage fate determination in the thymus. The first such finding is our demonstration here that ThPOK induced the expression of SOCS-encoding genes. The second is the fact that suppression of cytokine signaling in developing T cells prevents Runx3 expression and prevents CD8 + lineage specification 6 . Third is a report showing that CD4 T cells arise 'by default' in mice lacking both the ThPOK and Runx3 lineage-specifying transcription factors 27 . On the basis of those three findings, our observation here that enforced SOCS1 expression permitted the generation of CD4 + T cells in ThPOKdeficient mice can be explained as the differentiation of T cells that expressed neither ThPOK nor Runx3. Thus, this perspective suggests that CD4 + lineage 'choice' may require only the absence of Runx3 expression and that ThPOK during normal T cell development upregulates expression of genes encoding SOCS proteins that suppress Runx3 expression.
However, SOCS1 produced by transgenically enforced expression did not completely replace ThPOK in ThPOK-deficient mice, as some MHC class II-selected cells in Thpok −/− SOCS1-Tg mice differentiated into CD8 + T cells with mismatched TCRs and coreceptors. The appearance of T cells with such mismatch usually results from errors in lineage 'choice' during positive selection. We propose that the appearance of CD8 + T cells with such mismatch in Thpok −/− SOCS1-Tg mice could also be ascribed to erroneous lineage 'choices' that were the result of the failure of ThPOK-deficient thymocytes to upregulate CD4 expression during MHC class II-specific positive selection 26 . The upregulation of CD4 expression during MHC class II-specific positive selection is necessary to ensure that TCR signaling persists throughout selection 26 , but the factors responsible for this have not been previously identified, to our knowledge. Our study has now identified ThPOK as inducing the upregulation of CD4 expression during MHC class II-specific positive selection and has identified such upregulation as a function of ThPOK that cannot be achieved by SOCS1.
The previously unknown functions of ThPOK that we have identified in this study (induction of the expression of SOCS-encoding genes and upregulation of CD4 expression) provide new insights into the mechanism by which lineage 'choice' occurs during positive selection. As described in the kinetic signaling model 1, 16 , positive selecting TCR signals transiently inhibit cytokine signaling and induce the differentiation of CD4 + CD8 + double-positive cells into INT thymocytes that are transcriptionally Cd4 + Cd8 − and phenotypically CD69 + CD4 + CD8 lo . Because INT thymocytes maintain CD4 expression, MHC class II-specific positive selection signals persist to induce ThPOK expression 7 . We suggest that ThPOK then upregulates CD4 expression to maintain MHC class II signaling and upregulates genes encoding SOCS proteins to suppress cytokine signaling and prevent Runx3 expression, with cells then differentiating into mature CD4 + T cells. Conversely, because INT thymocytes lose CD8 expression, MHC class I-specific positive-selection signals cease, which allows intrathymic cytokines to induce Runx3 expression 6 . Runx3 then silences Thpok, silences Cd4 and reactivates Cd8 and thus causes INT thymocytes to undergo 'coreceptor reversal' and become transcriptionally Cd4 − Cd8 + cells that differentiate into mature CD8 + T cells 1, 28 .
In conclusion, our study has demonstrated that the expression of SOCS-encoding genes is the mechanism by which ThPOK represses Runx3 expression and imposes the CD4 + lineage fate during positive selection. Thus, SOCS-encoding genes have a critical role in lineagefate determination during positive selection in the thymus.
METhODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METhODS
Mice. C57BL/6, AND, and MHC class II-deficient mice were obtained from The Jackson Laboratory. SOCS1-Tg mice, which express cDNA encoding mouse SOCS1 under control of the proximal Lck promoter, have been described and were provided by M. Kubo 24 . Thpok hd/hd mice were provided by D. Kappes 12 . Thpok −/− and ThPOK-Tg mice (line C8) were provided by R. Bosselut 3, 25 . Mice with germline deficiency in Socs1 and Ifng were provided by James Ihle 29 . Human CD4-Socs1 reporter mice have been described 20 and were provided by T. Kay. Mice with transgenic expression of ThPOK were generated by cloning of cDNA encoding mouse ThPOK under the control of enhancer-promoter elements of the gene encoding human CD2, followed by injection into fertilized oocytes. Mice of both sexes between 4 and 16 weeks of age were used for analyses. Animal experiments were approved by the National Cancer Institute Animal Care and Use Committee, and all mice were cared for in accordance with guidelines of the US National Institutes of Health.
Flow cytometry. Lymphocytes were isolated from organs and were electronically sorted or were analyzed on a LSR II or FACSAria II. Lymph node cells were collected from the submandibular, inguinal, axillary and mesenteric lymph nodes. Dead cells were excluded by gating on forward light scatter and staining with propidium iodide. Flow cytometry data were analyzed with software designed by the Division of Computer Research and Technology at the US National Institutes of Health. The following antibodies were used for staining: antibody to TCRβ (anti-TCRβ; H57-957), anti-V α 11 (RR8-1), anti-CD4 (GK1.5) and anti-CD8α (53-6-7; all from BD Biosciences); anti-Qa-2 (69H1-9-9), anti-CD24 (M1/69), antibody to the α-chain of the receptor for interleukin 7 (anti-IL-7Rα; A7R34), antibody to the CD40 ligand (MR1), anti-CD69 (H1.2F3) and anti-CD103 (2EF; all from eBioscience); and anti-IL-4 (11B11) and anti-IFN-γ (XMg1.2; both from BioLegend).
Construction of mixed-bone marrow chimeras. Bone marrow chimeras were generated by reconstitution of irradiated (600 rads) Rag2 −/− recipient mice with donor bone marrow depleted of T cells and mixed at ratio of 1:1 (ThPOK-TgSocs1 +/+ to ThPOK-TgSocs1 −/− ; a total of 15 × 10 6 cells). Chimeric mice were analyzed 8-10 weeks after reconstitution.
In vitro T helper type 2 differentiation of CD4 + T cells. CD4 + and CD8 + T cells were sorted electronically from lymph nodes and were stimulated for 5 d with plate-bound anti-CD3 (145.2C11; BioLegend) and anti-CD28 (37.51; BioLegend), each at a concentration of 1 µg/ml, in the presence of recombinant mouse IL-4 (20 ng/ml; Peprotech) and anti-mouse IFN-γ (10 µg/ml; BioLegend). For intracellular staining of IL-4 and IFN-γ (both antibodies identified above), cells were restimulated for 3 h with PMA (phorbol 12-myristate 13-acetate) and ionomycin (both from Sigma) with the addition of brefeldin A, then were fixed and permeabilized with IC fixation buffer (eBioscience).
Luciferase reporter assay. The Matinspector software tool (Genomatix) and the rVista comparative tool (version 2.0) were used for analysis of evolutionarily conserved regions and potential ThPOK-binding sites in Socs1 and Cish. 5′ upstream regions of the transcriptional initiation sites corresponding to the Socs1 or Cish promoter were cloned into the promoterless pGL3-enhancer firefly luciferase reporter vector (Promega). cDNA encoding wild-type ThPOK or a mutant form of ThPOK whose BTB-POZ domain was destroyed was cloned into the pMACS LNGFR-IRES expression vector (Miltenyi Biotec). Luciferase reporter and ThPOK expression vectors were transfected together with pRL-CMV renilla luciferase vectors for normalization into 293T cells (American Type Culture Collection). Cell lysates were assayed with the Dual-Luciferase Reporter Assay System (Promega) and results were 'read' in a luminometer.
Quantitative RT-PCR. Total RNA was isolated from sorted cells with TRIzol (Invitrogen) or with an RNeasy Mini kit (Qiagen). RNA was reversetranscribed into cDNA by oligo(dT) priming with the QuantiTect Reverse Transcription kit (Qiagen). An ABI PRISM 7900HT Sequence Detection System and the QuantiTect SYBR Green detection system (Qiagen) were used for quantitative RT-PCR. Primers sequences are as follows. Socs1 (forward,
